CoTherix - Ownership and Business Overview

Life ScienceCompany

CoTherix Ownership

Who owns CoTherix?

CoTherix is owned by Actelion. It was acquired on November 20, 2006.

CoTherix Business Overview

Where is CoTherix headquartered?

CoTherix is headquartered in South San Francisco, California.

What sector is CoTherix in?

CoTherix is a life science company.

When was CoTherix founded?

CoTherix was founded in 2000.

Life Science M&A Summary in 2006

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.

Join Mergr to view all 120 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 98 by strategics.

CoTherix, Inc.

5000 Shoreline Court, Suite 101,
South San Francisco, California 94080
United States,
(650) 808-6500

CoTherix, Inc. is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the potential treatment of cardiovascular disease. CoTherix, Inc. licensed the exclusive U.S. rights to Ventavis® from Schering AG, which currently markets Ventavis® in Europe and Australia. In June 2006, CoTherix, Inc., licensed exclusive rights to develop and commercialize oral and inhaled formulations of Fasudil, a rho-kinase inhibitor, for the treatment of PAH and stable angina in North America and Europe from Asahi Kasei Pharma Corporation.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.